Bucindolol

No registered brands found for this active ingredient.

No food notes on record for this active ingredient.

• 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidineMODERATE

  The metabolism of Bucindolol can be decreased when combined with 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine.

  Expert view
• 1,10-PhenanthrolineMODERATE

  1,10-Phenanthroline may increase the bradycardic activities of Bucindolol.

  Expert view
• 3-isobutyl-1-methyl-7H-xanthineMODERATE

  The risk or severity of adverse effects can be increased when Bucindolol is combined with 3-isobutyl-1-methyl-7H-xanthine.

  Expert view
• 3,5-diiodothyropropionic acidMODERATE

  The risk or severity of adverse effects can be increased when Bucindolol is combined with 3,5-diiodothyropropionic acid.

  Expert view
• 3,5-DiiodotyrosineMODERATE

  The risk or severity of adverse effects can be increased when Bucindolol is combined with 3,5-Diiodotyrosine.

  Expert view
• 6-O-benzylguanineMODERATE

  The risk or severity of adverse effects can be increased when Bucindolol is combined with 6-O-benzylguanine.

  Expert view
• 7-DeazaguanineMODERATE

  The risk or severity of adverse effects can be increased when Bucindolol is combined with 7-Deazaguanine.

  Expert view
• 7,9-DimethylguanineMODERATE

  The risk or severity of adverse effects can be increased when Bucindolol is combined with 7,9-Dimethylguanine.

  Expert view
• 8-azaguanineMODERATE

  The risk or severity of adverse effects can be increased when Bucindolol is combined with 8-azaguanine.

  Expert view
• 9-DeazaguanineMODERATE

  The risk or severity of adverse effects can be increased when Bucindolol is combined with 9-Deazaguanine.

  Expert view